Sign inGet started

CANO

Cano Health, Inc.CIK 1800682 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
20

AI insights for CANO PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for CANO
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Nussbaum Jared R.10% Owner6$0$02024-06-28
Gil EladioInterim CFO2$0$02024-06-28
Kent Mark D.Interim CEO9$0$02024-06-28
Camerlinck RobertChief Operating Officer11$0$23.6K2024-06-28
Armstrong David JSee remarks20$150.3K$4.4K2024-06-28
Morales Angel LDirector8$0$02024-06-28
Rivera Kim MDirector4$0$02024-06-28
MUNEY ALANDirector4$0$02024-06-28
TRUJILLO SOLOMON DDirector9$1.02M$02024-06-28
Cooperstone ElliotDirector, 10% Owner22$0$2.01M2024-02-01
ITC Rumba, LLC10% Owner15$0$1.97M2024-01-29
Hernandez MarlowDirector60$20.36M$02023-07-12
Aguilar RichardChief Clinical Officer38$16.21M$2.44M2023-06-29
Guichelaar JacquelineDirector3$0$02023-06-15
Novell MarkChief Accounting Officer10$0$02023-05-31
Koppy Brian DChief Financial Officer11$0$30.0K2023-05-31
Gold LewisDirector12$2.04M$02022-05-16
STERNLICHT BARRY SDirector, 10% Owner8$0$02022-05-16
Jaws Sponsor LLC10% Owner5$0$02021-07-21
Dowling Joseph L IIIChief Executive Officer1$0$02021-06-04

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Kent Mark D.Interim CEO A Award deriv2024-06-282024-07-0294,416— $094,416SEC↗
Nussbaum Jared R.10% Owner J Other deriv2024-06-282024-07-0232,750— $032,750SEC↗
Nussbaum Jared R.10% Owner J Other deriv2024-06-282024-07-02347,603— $0347,603SEC↗
Nussbaum Jared R.10% Owner J Other deriv2024-06-282024-07-0217,054— $017,054SEC↗
MUNEY ALANDirector D To issuer2024-06-282024-07-022,485— $00SEC↗
TRUJILLO SOLOMON DDirector D To issuer2024-06-282024-07-023,782— $00SEC↗
TRUJILLO SOLOMON DDirector D To issuer2024-06-282024-07-02136,804— $00SEC↗
Morales Angel LDirector D To issuer2024-06-282024-07-0269,685— $00SEC↗
Morales Angel LDirector D To issuer2024-06-282024-07-022,485— $00SEC↗
Camerlinck RobertChief Operating Officer D To issuer2024-06-282024-07-02269,586— $00SEC↗
Armstrong David JSee remarks D To issuer2024-06-282024-07-026,641— $00SEC↗
Rivera Kim MDirector D To issuer2024-06-282024-07-022,485— $00SEC↗
Kent Mark D.Interim CEO D To issuer2024-06-282024-07-0215,296— $00SEC↗
Kent Mark D.Interim CEO D To issuer2024-06-282024-07-021,749— $00SEC↗
Kent Mark D.Interim CEO D To issuer2024-06-282024-07-0223,609— $00SEC↗
Kent Mark D.Interim CEO D To issuer2024-06-282024-07-0223,609— $00SEC↗
Kent Mark D.Interim CEO D To issuer2024-06-282024-07-0245,995— $00SEC↗
Kent Mark D.Interim CEO D To issuer2024-06-282024-07-021,749— $00SEC↗
Gil EladioInterim CFO D To issuer2024-06-282024-07-027,676— $00SEC↗
Nussbaum Jared R.10% Owner J Other2024-06-282024-07-029,557,095— $09,557,095SEC↗
Nussbaum Jared R.10% Owner J Other2024-06-282024-07-02555,508— $0555,508SEC↗
Nussbaum Jared R.10% Owner J Other2024-06-282024-07-02912,538— $0912,538SEC↗
Cooperstone Elliot10% Owner S Sale2024-02-012024-02-021,100$2.53 $2.8K516,007SEC↗
Cooperstone Elliot10% Owner S Sale2024-01-312024-02-028,935$2.59 $23.1K517,107SEC↗
Cooperstone Elliot10% Owner S Sale2024-01-302024-02-0212,703$2.70 $34.3K526,042SEC↗
ITC Rumba, LLC10% Owner S Sale2024-01-292024-01-2941,357$2.74 $113.3K538,745SEC↗
ITC Rumba, LLC10% Owner S Sale2024-01-262024-01-2932,693$2.74 $89.6K580,102SEC↗
ITC Rumba, LLC10% Owner S Sale2024-01-252024-01-2918,569$2.58 $47.9K612,795SEC↗
ITC Rumba, LLC10% Owner S Sale2024-01-242024-01-2435,808$2.84 $101.7K631,364SEC↗
ITC Rumba, LLC10% Owner S Sale2024-01-232024-01-2473,034$2.94 $214.7K667,172SEC↗
ITC Rumba, LLC10% Owner S Sale2024-01-222024-01-24125,000$2.50 $312.5K740,206SEC↗
ITC Rumba, LLC10% Owner S Sale2024-01-182024-01-19100,000$1.91 $191.0K865,206SEC↗
ITC Rumba, LLC10% Owner S Sale2024-01-172024-01-195,987$2.92 $17.5K965,206SEC↗
ITC Rumba, LLC10% Owner S Sale2024-01-172024-01-1994,013$2.28 $214.3K971,193SEC↗
Cooperstone Elliot10% Owner C Conversion deriv2024-01-122024-01-121,065,206— $00SEC↗
Cooperstone Elliot10% Owner C Conversion deriv2024-01-122024-01-121,065,206— $01,065,206SEC↗
Cooperstone Elliot10% Owner S Sale2024-01-122024-01-1224,171$3.30 $79.8K0SEC↗
Cooperstone Elliot10% Owner C Conversion2024-01-122024-01-121,065,206— $01,065,206SEC↗
Cooperstone Elliot10% Owner S Sale2024-01-112024-01-1225,000$3.59 $89.8K24,171SEC↗
Cooperstone Elliot10% Owner S Sale2024-01-102024-01-1225,000$3.73 $93.3K49,171SEC↗
Cooperstone Elliot10% Owner S Sale2024-01-092024-01-0925,000$3.75 $93.8K74,171SEC↗
Cooperstone Elliot10% Owner S Sale2024-01-082024-01-0925,000$3.82 $95.5K99,171SEC↗
Cooperstone Elliot10% Owner S Sale2024-01-052024-01-0925,000$3.85 $96.3K124,171SEC↗
Cooperstone Elliot10% Owner S Sale2024-01-042024-01-0413,328$4.00 $53.3K149,171SEC↗
Cooperstone Elliot10% Owner S Sale2024-01-032024-01-0424,182$4.94 $119.5K162,499SEC↗
Cooperstone Elliot10% Owner S Sale2024-01-032024-01-0450,818$4.08 $207.3K186,681SEC↗
Cooperstone Elliot10% Owner S Sale2024-01-022024-01-0443,505$5.42 $235.8K237,499SEC↗
ITC Rumba, LLC10% Owner S Sale2023-12-292023-12-2935,112$6.00 $210.7K281,004SEC↗
ITC Rumba, LLC10% Owner S Sale2023-12-282023-12-2941,197$6.00 $247.2K316,116SEC↗
ITC Rumba, LLC10% Owner S Sale2023-12-272023-12-2937,607$5.65 $212.5K357,313SEC↗
Cooperstone Elliot10% Owner S Sale2023-12-262023-12-2621,154$5.44 $115.1K394,920SEC↗
Cooperstone Elliot10% Owner S Sale2023-12-222023-12-2627,377$5.65 $154.7K416,074SEC↗
Cooperstone Elliot10% Owner S Sale2023-12-212023-12-2682,843$5.67 $469.7K449,760SEC↗
Cooperstone Elliot10% Owner S Sale2023-12-212023-12-266,309$6.62 $41.8K443,451SEC↗
ITC Rumba, LLC10% Owner C Conversion deriv2023-12-152023-12-19532,603— $01,065,206SEC↗
ITC Rumba, LLC10% Owner C Conversion deriv2023-12-152023-12-19532,603— $01,065,206SEC↗
ITC Rumba, LLC10% Owner C Conversion2023-12-152023-12-19532,603— $0532,603SEC↗
TRUJILLO SOLOMON DDirector C Conversion deriv2023-12-072023-12-08136,804— $00SEC↗
TRUJILLO SOLOMON DDirector C Conversion deriv2023-12-072023-12-08136,804— $00SEC↗
TRUJILLO SOLOMON DDirector C Conversion2023-12-072023-12-08136,804— $0136,804SEC↗
Morales Angel LDirector C Conversion deriv2023-11-202023-11-2269,685— $00SEC↗
Morales Angel LDirector C Conversion deriv2023-11-202023-11-2269,685— $00SEC↗
Morales Angel LDirector C Conversion2023-11-202023-11-2269,685— $069,685SEC↗
Gil EladioInterim CFO A Award2023-11-102023-11-147,676— $07,676SEC↗
Camerlinck RobertChief Operating Officer S Sale2023-08-112023-08-1530,646$0.77 $23.6K26,958,642SEC↗
Hernandez MarlowDirector A Award2023-07-122023-07-14189,681— $04,942,605SEC↗
Kent Mark D.Interim CEO A Award2023-07-122023-07-14216,237— $0391,606SEC↗
Kent Mark D.Interim CEO A Award2023-07-122023-07-141,138,088— $01,529,694SEC↗
Armstrong David JSee remarks A Award2023-06-302023-07-147,506$0.77 $5.8K664,132SEC↗
Aguilar RichardChief Clinical Officer S Sale2023-06-292023-06-30400,000$1.31 $524.0K1,213,984SEC↗
Aguilar RichardChief Clinical Officer S Sale2023-06-282023-06-30150,000$1.22 $183.0K1,613,984SEC↗
Aguilar RichardChief Clinical Officer C Conversion deriv2023-06-262023-06-28550,000— $04,742,276SEC↗
Aguilar RichardChief Clinical Officer C Conversion deriv2023-06-262023-06-28550,000— $04,742,276SEC↗
Aguilar RichardChief Clinical Officer C Conversion2023-06-262023-06-28550,000— $01,763,984SEC↗
Guichelaar JacquelineDirector A Award2023-06-152023-06-20185,598— $0248,500SEC↗
Morales Angel LDirector A Award2023-06-152023-06-20185,598— $0248,500SEC↗
MUNEY ALANDirector A Award2023-06-152023-06-20185,598— $0248,500SEC↗
Rivera Kim MDirector A Award2023-06-152023-06-20185,598— $0248,500SEC↗
TRUJILLO SOLOMON DDirector A Award2023-06-152023-06-20211,581— $0378,214SEC↗
Aguilar RichardChief Clinical Officer S Sale2023-06-122023-06-13500,000$1.42 $710.0K1,213,984SEC↗
Aguilar RichardChief Clinical Officer S Sale2023-06-092023-06-13100,000$1.38 $138.0K1,713,984SEC↗
Aguilar RichardChief Clinical Officer G Gift2023-06-082023-06-13600,000— $00SEC↗
Aguilar RichardChief Clinical Officer G Gift2023-06-082023-06-13600,000— $02,089,924SEC↗
Aguilar RichardChief Clinical Officer S Sale2023-06-082023-06-13275,940$1.29 $356.0K1,813,984SEC↗
Aguilar RichardChief Clinical Officer S Sale2023-06-072023-06-13400,000$1.32 $528.0K1,489,924SEC↗
Armstrong David JSee remarks S Sale2023-06-062023-06-073,163$1.38 $4.4K656,626SEC↗
Novell MarkChief Accounting Officer A Award2023-05-312023-06-0260,502— $0232,067SEC↗
Hernandez MarlowCEO A Award2023-05-312023-06-02671,742— $04,701,256SEC↗
Armstrong David JSee remarks A Award2023-05-312023-06-02109,526— $0659,789SEC↗
Koppy Brian DChief Financial Officer A Award2023-05-312023-06-02248,226— $01,050,796SEC↗
Aguilar RichardChief Clinical Officer A Award2023-05-312023-06-02231,008— $01,213,984SEC↗
Camerlinck RobertChief Operating Officer A Award2023-05-312023-06-02239,139— $026,989,288SEC↗
Aguilar RichardChief Clinical Officer C Conversion deriv2023-05-252023-06-13600,000— $05,292,276SEC↗
Aguilar RichardChief Clinical Officer C Conversion deriv2023-05-252023-06-13675,940— $00SEC↗
Aguilar RichardChief Clinical Officer C Conversion deriv2023-05-252023-06-13675,940— $00SEC↗
Aguilar RichardChief Clinical Officer C Conversion deriv2023-05-252023-06-13600,000— $05,292,276SEC↗
Aguilar RichardChief Clinical Officer C Conversion2023-05-252023-06-13675,940— $01,889,924SEC↗
Aguilar RichardChief Clinical Officer C Conversion2023-05-252023-06-13600,000— $0600,000SEC↗
Novell MarkChief Accounting Officer A Award deriv2023-04-112023-04-1332,131— $032,131SEC↗
Novell MarkChief Accounting Officer A Award2023-04-112023-04-1351,684— $0171,565SEC↗
Aguilar RichardChief Clinical Officer P Buy deriv2023-04-052023-04-064,991,807— $04,991,807SEC↗
Aguilar RichardChief Clinical Officer S Sale deriv2023-04-052023-04-064,991,807— $05,892,276SEC↗
Aguilar RichardChief Clinical Officer S Sale deriv2023-04-052023-04-064,991,807— $05,892,276SEC↗
Hernandez MarlowCEO S Sale deriv2023-04-052023-04-068,536,936— $013,497,686SEC↗
Hernandez MarlowCEO S Sale deriv2023-04-052023-04-068,536,936— $013,497,686SEC↗
Hernandez MarlowCEO P Buy deriv2023-04-052023-04-068,536,936— $08,536,936SEC↗
Camerlinck RobertChief Operating Officer S Sale deriv2023-04-052023-04-1020,000,000— $00SEC↗
Camerlinck RobertChief Operating Officer J Other deriv2023-04-052023-04-1017,163,460— $017,163,460SEC↗
Camerlinck RobertChief Operating Officer J Other deriv2023-04-052023-04-1017,163,460— $017,163,460SEC↗
Koppy Brian DChief Financial Officer S Sale2023-04-052023-04-0723,591$1.27 $30.0K802,570SEC↗
Camerlinck RobertChief Operating Officer J Other2023-04-052023-04-102,836,540— $026,750,149SEC↗
Hernandez MarlowCEO A Award deriv2023-03-312023-04-04729,730— $0729,730SEC↗
Koppy Brian DChief Financial Officer A Award deriv2023-03-312023-04-04260,000— $0260,000SEC↗
Camerlinck RobertChief Operating Officer A Award deriv2023-03-312023-04-04147,548— $0147,548SEC↗
Aguilar RichardChief Clinical Officer A Award deriv2023-03-312023-04-04195,676— $0195,676SEC↗
Armstrong David JSee remarks A Award deriv2023-03-312023-04-04146,757— $0146,757SEC↗
Armstrong David JSee remarks C Conversion deriv2023-03-312023-06-28185,000— $0689,453SEC↗
Armstrong David JSee remarks C Conversion deriv2023-03-312023-06-28185,000— $0689,453SEC↗
Hernandez MarlowCEO A Award2023-03-312023-04-04348,604— $04,029,514SEC↗
Koppy Brian DChief Financial Officer A Award2023-03-312023-04-04124,206— $0826,161SEC↗
Camerlinck RobertChief Operating Officer A Award2023-03-312023-04-0470,486— $023,913,609SEC↗
Aguilar RichardChief Clinical Officer A Award2023-03-312023-04-04120,116— $0982,976SEC↗
Armstrong David JSee remarks A Award2023-03-312023-04-0470,108— $0550,263SEC↗
Armstrong David JSee remarks C Conversion2023-03-312023-06-28185,000— $0841,626SEC↗
Aguilar RichardChief Clinical Officer F Tax w/h2023-01-052023-01-0927,010$1.08 $29.2K862,860SEC↗
Novell MarkChief Accounting Officer F Tax w/h2023-01-052023-01-094,538$1.08 $4.9K119,881SEC↗
Armstrong David JSee remarks F Tax w/h2023-01-052023-01-0919,749$1.08 $21.3K480,155SEC↗
Koppy Brian DChief Financial Officer F Tax w/h2023-01-052023-01-0928,528$1.08 $30.8K701,955SEC↗
Hernandez MarlowCEO A Award2023-01-032023-01-05134,660$0.87 $117.2K3,680,910SEC↗
Armstrong David JSee remarks A Award2023-01-032023-01-0513,006$0.87 $11.3K499,904SEC↗
Hernandez MarlowCEO J Other deriv2022-12-272022-12-2911,017,311— $022,034,622SEC↗
Hernandez MarlowCEO J Other deriv2022-12-272022-12-2911,017,311— $022,034,622SEC↗
Hernandez MarlowCEO J Other2022-12-272022-12-2911,017,311— $00SEC↗
Camerlinck RobertChief Operating Officer J Other2022-09-012022-09-0625,386— $023,843,123SEC↗
Armstrong David JSee remarks F Tax w/h2022-08-312022-09-0220,500$5.95 $122.0K486,898SEC↗
Novell MarkChief Accounting Officer F Tax w/h2022-08-312022-09-027,387$5.95 $44.0K124,419SEC↗
Koppy Brian DChief Financial Officer F Tax w/h2022-08-312022-09-0213,651$5.95 $81.2K730,483SEC↗
Novell MarkChief Accounting Officer A Award2022-08-102022-08-1224,000— $0131,806SEC↗
Camerlinck RobertChief Operating Officer A Award2022-08-102022-08-12250,000— $023,817,737SEC↗
Armstrong David JSee remarks A Award2022-07-052022-07-074,828$3.52 $17.0K507,398SEC↗
Hernandez MarlowCEO A Award2022-07-052022-07-0729,870$3.52 $105.1K3,546,250SEC↗
Armstrong David JSee remarks F Tax w/h2022-06-072022-06-083,254$5.14 $16.7K502,570SEC↗
Hernandez MarlowCEO and President C Conversion deriv2022-05-262022-05-3111,017,311— $011,017,311SEC↗
Hernandez MarlowCEO and President C Conversion deriv2022-05-262022-05-3111,017,311— $011,017,311SEC↗
Hernandez MarlowCEO and President C Conversion2022-05-262022-05-3111,017,311— $011,017,311SEC↗
Rivera Kim MDirector A Award2022-05-162022-05-1848,077— $062,902SEC↗
Morales Angel LDirector A Award2022-05-162022-05-1848,077— $062,902SEC↗
Guichelaar JacquelineDirector A Award2022-05-162022-05-1848,077— $062,902SEC↗
Cooperstone ElliotDirector, 10% Owner A Award2022-05-162022-05-1848,077— $062,902SEC↗
MUNEY ALANDirector A Award2022-05-162022-05-1848,077— $062,902SEC↗
TRUJILLO SOLOMON DDirector A Award2022-05-162022-05-1854,808— $0166,633SEC↗
Gold LewisDirector A Award2022-05-162022-05-1848,077— $0362,902SEC↗
STERNLICHT BARRY SDirector, 10% Owner A Award2022-05-162022-05-1848,077— $012,854,233SEC↗
Koppy Brian DChief Financial Officer F Tax w/h2022-05-092022-05-1240,484$4.38 $177.3K744,134SEC↗
Gold LewisDirector C Conversion deriv2022-03-212022-03-2110,000— $01,233,085SEC↗
Gold LewisDirector C Conversion deriv2022-03-212022-03-2110,000— $01,233,085SEC↗
Gold LewisDirector C Conversion2022-03-212022-03-2110,000— $01,233,085SEC↗
Gold LewisDirector P Buy2022-03-172022-03-21300,000$6.81 $2.04M314,825SEC↗
Novell MarkChief Accounting Officer A Award deriv2022-03-152022-03-176,449— $06,449SEC↗
Koppy Brian DChief Financial Officer A Award deriv2022-03-152022-03-1736,681— $036,681SEC↗
Aguilar RichardChief Clinical Officer A Award deriv2022-03-152022-03-1737,320— $037,320SEC↗
Armstrong David JSee remarks A Award deriv2022-03-152022-03-1727,990— $027,990SEC↗
Hernandez MarlowCEO A Award deriv2022-03-152022-03-17139,175— $0139,175SEC↗
Novell MarkChief Accounting Officer A Award2022-03-152022-03-1728,783— $057,806SEC↗
Koppy Brian DChief Financial Officer A Award2022-03-152022-03-17181,280— $0784,618SEC↗
Aguilar RichardChief Clinical Officer A Award2022-03-152022-03-17171,641— $0889,870SEC↗
Armstrong David JSee remarks A Award2022-03-152022-03-17125,474— $0505,824SEC↗
Hernandez MarlowCEO A Award2022-03-152022-03-17624,418— $03,516,380SEC↗
Novell MarkChief Accounting Officer A Award2022-03-152022-03-2250,000— $0107,806SEC↗
Gold LewisDirector C Conversion deriv2022-02-072022-02-09158,850— $0158,850SEC↗
Gold LewisDirector C Conversion deriv2022-02-072022-02-09158,850— $0158,850SEC↗
Gold LewisDirector C Conversion deriv2022-02-072022-02-091,223,085— $01,223,085SEC↗
Gold LewisDirector C Conversion deriv2022-02-072022-02-091,223,085— $01,223,085SEC↗
Gold LewisDirector C Conversion2022-02-072022-02-091,223,085— $01,223,085SEC↗
Gold LewisDirector C Conversion2022-02-072022-02-09158,850— $0158,850SEC↗
Cooperstone ElliotDirector, 10% Owner A Award2022-01-282022-02-0114,825— $014,825SEC↗
MUNEY ALANDirector A Award2022-01-282022-02-0114,825— $014,825SEC↗
Gold LewisDirector A Award2022-01-282022-02-0114,825— $014,825SEC↗
TRUJILLO SOLOMON DDirector A Award2022-01-282022-02-0114,825— $0111,825SEC↗
STERNLICHT BARRY SDirector, 10% Owner A Award2022-01-282022-02-0114,825— $014,825SEC↗
Morales Angel LDirector A Award2022-01-282022-02-0114,825— $014,825SEC↗
Guichelaar JacquelineDirector A Award2022-01-282022-02-0114,825— $014,825SEC↗
Rivera Kim MDirector A Award2022-01-282022-02-0114,825— $014,825SEC↗
Aguilar RichardChief Clinical Officer A Award2022-01-182022-01-20200,000— $0771,229SEC↗
Armstrong David JSee remarks A Award2022-01-182022-01-2050,000— $0380,350SEC↗
Koppy Brian DChief Financial Officer A Award2022-01-132022-01-18373,972— $0603,338SEC↗
Aguilar RichardChief Clinical Officer J Other2021-12-222021-12-22119,407— $0529,895SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-12-062021-12-0714,999$2.20 $33.0K473,469SEC↗
Hernandez MarlowCEO and President P Buy2021-12-062021-12-0715,000$8.00 $120.0K2,891,962SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-12-032021-12-0622,001$2.38 $52.4K458,470SEC↗
Hernandez MarlowCEO and President P Buy2021-12-032021-12-0612,500$8.75 $109.4K2,876,962SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-12-012021-12-0610,000$2.59 $25.9K436,469SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-11-302021-12-0115,000$2.39 $35.9K426,469SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-11-232021-11-2420,000$2.40 $48.0K411,469SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-11-222021-11-2410,000$2.60 $26.0K391,469SEC↗
Hernandez MarlowCEO and President P Buy2021-11-222021-11-248,000$9.65 $77.2K2,864,462SEC↗
TRUJILLO SOLOMON DDirector P Buy2021-11-182021-11-3097,000$10.55 $1.02M97,000SEC↗
Armstrong David JSee remarks A Award2021-09-212021-09-24285,333— $0300,333SEC↗
Aguilar RichardChief Clinical Officer A Award2021-09-212021-09-24285,333— $0410,488SEC↗
Koppy Brian DChief Financial Officer A Award2021-09-212021-09-24190,000— $0190,000SEC↗
Hernandez MarlowCEO and President A Award2021-09-212021-09-241,339,500— $02,856,462SEC↗
Novell MarkChief Accounting Officer A Award2021-09-212021-09-2729,023— $029,023SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-09-042021-09-0870,000$10.75 $752.5K70,000SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-09-042021-09-0870,000$10.75 $752.5K70,000SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-08-312021-09-0240,419$3.77 $152.4K46,987SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-08-312021-09-0294,311$3.77 $355.6K381,469SEC↗
Hernandez MarlowCEO and President P Buy2021-08-312021-09-022,500$11.99 $30.0K67,597SEC↗
Hernandez MarlowCEO and President P Buy2021-08-312021-09-025,833$11.99 $69.9K1,516,962SEC↗
Aguilar RichardChief Clinical Officer P Buy deriv2021-08-302021-08-31651,163$10.75 $7.00M651,163SEC↗
Aguilar RichardChief Clinical Officer P Buy deriv2021-08-302021-08-31651,163$10.75 $7.00M651,163SEC↗
Aguilar RichardChief Clinical Officer P Buy deriv2021-08-302021-09-1424,777$10.75 $266.4K675,940SEC↗
Aguilar RichardChief Clinical Officer P Buy deriv2021-08-302021-09-1424,777$10.75 $266.4K675,940SEC↗
Hernandez MarlowCEO and President P Buy2021-08-302021-08-311,173,276$10.75 $12.61M1,511,129SEC↗
Hernandez MarlowCEO and President P Buy2021-08-302021-08-312,500$11.92 $29.8K65,097SEC↗
Hernandez MarlowCEO and President P Buy2021-08-302021-08-315,833$11.87 $69.2K337,853SEC↗
Aguilar RichardChief Clinical Officer P Buy2021-08-302021-09-011,749$11.93 $20.9K125,155SEC↗
Hernandez MarlowCEO and President P Buy2021-08-272021-08-312,500$11.77 $29.4K62,597SEC↗
Hernandez MarlowCEO and President P Buy2021-08-272021-08-315,833$11.84 $69.1K332,020SEC↗
Aguilar RichardChief Clinical Officer P Buy deriv2021-08-262021-08-3138,589$3.81 $147.0K46,710SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-08-262021-08-313,896$3.81 $14.8K6,568SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-08-262021-08-319,091$3.81 $34.6K287,158SEC↗
Aguilar RichardChief Clinical Officer P Buy2021-08-262021-08-3172,013$11.99 $863.4K123,406SEC↗
Hernandez MarlowCEO and President P Buy2021-08-262021-08-316,240$11.62 $72.5K60,097SEC↗
Hernandez MarlowCEO and President P Buy2021-08-262021-08-3114,560$11.79 $171.7K326,187SEC↗
Aguilar RichardChief Clinical Officer P Buy deriv2021-08-252021-08-318,121$3.62 $29.4K8,121SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-08-252021-08-312,672$3.62 $9.7K2,672SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-08-252021-08-316,235$3.62 $22.6K278,067SEC↗
Aguilar RichardChief Clinical Officer P Buy2021-08-252021-08-3151,393$11.93 $613.1K51,393SEC↗
Hernandez MarlowCEO and President P Buy2021-08-252021-08-3153,857$11.94 $643.1K53,857SEC↗
Hernandez MarlowCEO and President P Buy2021-08-252021-08-3154,727$11.93 $652.9K311,627SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-08-202021-08-235,000$2.75 $13.8K271,832SEC↗
Hernandez MarlowCEO and President P Buy2021-08-202021-08-2310,000$10.20 $102.0K256,900SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-08-192021-08-2315,000$2.89 $43.4K266,832SEC↗
Hernandez MarlowCEO and President P Buy2021-08-192021-08-2325,000$10.38 $259.5K246,900SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-08-182021-08-231,832$2.30 $4.2K251,832SEC↗
Armstrong David JSee remarks A Award2021-08-182021-08-1915,000$10.02 $150.3K15,000SEC↗
Hernandez MarlowCEO and President P Buy2021-08-182021-08-2311,900$9.82 $116.9K221,900SEC↗
Armstrong David JSee remarks P Buy2021-08-182021-08-2415,000$10.02 $150.3K15,000SEC↗
Hernandez MarlowCEO and President A Award deriv2021-08-172021-08-1890,000$2.51 $225.9K250,000SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-08-172021-08-2390,000$2.51 $225.9K250,000SEC↗
Hernandez MarlowCEO and President A Award2021-08-172021-08-1890,000$9.55 $859.5K210,000SEC↗
Hernandez MarlowCEO and President P Buy2021-08-172021-08-2390,000$9.55 $859.5K210,000SEC↗
Hernandez MarlowCEO and President A Award deriv2021-08-162021-08-18160,000$2.77 $443.2K160,000SEC↗
Hernandez MarlowCEO and President P Buy deriv2021-08-162021-08-23160,000$2.77 $443.2K160,000SEC↗
Hernandez MarlowCEO and President A Award2021-08-162021-08-18120,000$10.16 $1.22M120,000SEC↗
Hernandez MarlowCEO and President P Buy2021-08-162021-08-23120,000$10.16 $1.22M120,000SEC↗
STERNLICHT BARRY SDirector, 10% Owner J Other deriv2021-07-212021-07-232,688,694— $07,844,639SEC↗
Jaws Sponsor LLC10% Owner J Other deriv2021-07-212021-07-2310,533,333— $00SEC↗
STERNLICHT BARRY SDirector, 10% Owner J Other2021-07-212021-07-234,383,669— $034,831,848SEC↗
Jaws Sponsor LLC10% Owner J Other2021-07-212021-07-2317,175,000— $00SEC↗
STERNLICHT BARRY SDirector, 10% Owner J Other deriv2021-06-042021-06-0717,175,000— $00SEC↗
STERNLICHT BARRY SDirector, 10% Owner J Other deriv2021-06-042021-06-0710,533,333$1.50 $15.80M10,533,333SEC↗
Jaws Sponsor LLC10% Owner J Other deriv2021-06-042021-06-0710,533,333$1.50 $15.80M10,533,333SEC↗
Jaws Sponsor LLC10% Owner J Other deriv2021-06-042021-06-0717,175,000— $00SEC↗
STERNLICHT BARRY SDirector, 10% Owner J Other2021-06-042021-06-0717,175,000— $017,175,000SEC↗
STERNLICHT BARRY SDirector, 10% Owner A Award2021-06-042021-06-074,865,517$10.00 $48.66M22,040,517SEC↗
Jaws Sponsor LLC10% Owner J Other2021-06-042021-06-0717,175,000— $017,175,000SEC↗
Dowling Joseph L IIIChief Executive Officer A Award2021-06-042021-06-0752,500$10.00 $525.0K52,500SEC↗